Nurix Therapeutics, Inc. SEC filings NRIX
Nurix Therapeutics, Inc. has 561 filings in SEC EDGAR's recent list, going back to May 15, 2012. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Nov 30, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 13, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on November 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Mar 27, 2026 | Nov 30, 2025 |
| 10-K | Annual report | Jan 28, 2026 | Nov 30, 2025 |
| ARS | Annual report to shareholders | Mar 28, 2025 | Nov 30, 2024 |
| 10-K | Annual report | Jan 28, 2025 | Nov 30, 2024 |
| ARS | Annual report to shareholders | Mar 27, 2024 | Nov 30, 2023 |
| 10-K | Annual report | Feb 15, 2024 | Nov 30, 2023 |
| ARS | Annual report to shareholders | Mar 24, 2023 | Nov 30, 2022 |
| 10-K | Annual report | Feb 9, 2023 | Nov 30, 2022 |
| 10-K | Annual report | Jan 28, 2022 | Nov 30, 2021 |
| 10-K | Annual report | Feb 16, 2021 | Nov 30, 2020 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NRIX (Nasdaq)
- Fiscal year ends
- November 30
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1549595
- Former names
- Nurix, Inc. (until Sep 18, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.